View Page
Export to PDF
Version history
View ownership
Content Information
View Source
Convert Gliffy Diagrams
Content
…
FAQs
FAQ articles
About the CanRisk Tool
How are rare genetic pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2 , RAD51C, RAD51D, and BRIP1 used in the CanRisk Tool?
Content Comparison
Versions Compared
Version
Old Version
3
New Version
4
Changes made by
Tim Carver
Tim Carver
Saved on
May 27, 2021
May 27, 2021
Previous Change: Difference between versions 2 and 3
Next Change: Difference between versions 4 and 5
View Version History
Key
This line was added.
This line was removed.
Formatting was changed.
The CanRisk Tool only considers the effects of truncating variants in ATM
and CHEK2
. Please see the explanation for this in the Discussion section of the
Genet. Med. 18, 1190–1198 (2016)
.
General
Content
Integrations
App links
{"serverDuration": 146, "requestCorrelationId": "e9a4e72c1f1f4ded936b8b8346fe790a"}